Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Bracco U.K. Ltd, Unit 15, Valley Business Centre, Gordon Road, High Wycombe, Buckinghamshire HP13 6EQ, United Kingdom
E-Z-Paque 96 % w/w powder for oral suspension.
| Pharmaceutical Form |
|---|
|
Powder for oral suspension. White powder with a vanilla and strawberry odour. |
Active Constituent: Barium sulfate 96% w/w
Excipients with known effect (per 100 g of powder):
Sorbitol (E420), 2.2 g.
Propylene glycol: 77 mg
Sodium: 121 mg.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Barium sulfate |
Barium sulfate is inert and has no pharmacological action. It serves only as a radiopaque substance to opacify the gastro-intestinal tract during X-ray examinations. |
| List of Excipients |
|---|
|
Sorbitol (E420) |
E-Z-Paque is presented as follows: Unit dose bottle (containing 177g E-Z-Paque) composed of a high density polyethylene (HDPE) with a polypropylene screw lid having a liner of three-ply co-extruded material (a foamed, low density polyethylene core between two solid layers of low density polyethylene).
Bracco U.K. Ltd, Unit 15, Valley Business Centre, Gordon Road, High Wycombe, Buckinghamshire HP13 6EQ, United Kingdom
PL 18920/0030
29 April 1994 / 11 November 1995
| Drug | Countries | |
|---|---|---|
| E-Z-PAQUE | United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
